Current Status and Potential of Immune Adjuvants in Mycotoxin Immune Enhancement: Mechanisms, Innovations, and Applications
Bibliographic record
Abstract
Mycotoxins are toxic and impair the immunological effect of other vaccines upon exposure. To mitigate the adverse effects of mycotoxins, detection, and vaccine prevention are crucial. The acquisition of monoclonal antibodies and the production of specific antibodies are key in detection and vaccine prevention, both of which require robust antigen immunological effect. Summarizing the toxic characteristics of mycotoxins reveals that they primarily exert their toxicity through mechanisms such as oxidative stress and apoptosis, resulting in poor and unstable immune responses. As essential adjuvants for enhancing antigen-specific immune responses, adjuvants hold significant potential for improving the immunogenicity of low-immunogenic, highly immunotoxic mycotoxins. In this review, we categorize adjuvants into immunomodulatory, carrier-based, and composite types, introducing their mechanisms and latest advancements, which demonstrate the evolution of adjuvant functions from uncontrolled single immune activation to controllable targeted immune modulation. Notably, we innovatively integrate mycotoxin toxicity mechanisms with adjuvant immune enhancement mechanisms, emphasizing the applications of these adjuvant platforms in alleviating mycotoxin toxicity while exerting immune-enhancing effects. Concurrently, we discuss regulatory aspects, challenges, and future prospects for immunostimulatory adjuvants. To provide systematic literature analysis for the rational application of immune adjuvants in mycotoxin immune enhancement and the design and development of novel immune adjuvants.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.001 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.000 |
| Bibliometrics | 0.002 | 0.001 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.001 | 0.001 |
| Open science | 0.001 | 0.000 |
| Research integrity | 0.001 | 0.001 |
| Insufficient payload (model declined to judge) | 0.002 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".